Granisetron transdermal system and dexamethasone for the prevention of nausea and vomiting in multiple myeloma patients receiving chemo-mobilization: An observational real-world study of effectiveness and safety

Cyclophosphamide (CY) in a dose of 2–4 g/m2 is widely used for hemopoietic progenitor stem cells mobilization. CY administration is associated with several adverse effects, including chemotherapy-induced nausea and vomiting (CINV). This study aimed to evaluate the efficacy and tolerability of granis...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Transfusion and apheresis science 2020-12, Vol.59 (6), p.102911-102911, Article 102911
Hauptverfasser:	Martino, Massimo, Naso, Virginia, Porto, Gaetana, Paviglianiti, Annalisa, Ferreri, Anna, Loteta, Barbara, Moscato, Tiziana, Console, Giuseppe, Gentile, Massimo, Rossi, Marco, Provenzano, Pasquale Fabio, Gori, Mercedes, Pitino, Anna Lisa, Morabito, Antonella, Tripepi, Giovanni
Format:	Artikel
Sprache:	eng
Schlagworte:	Granisetron Health technology assessment Mobilization Multiple myeloma Nausea Transdermal Vomiting
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!